Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Clinical trial NCT02342444 · UNKNOWN

Trial details

NCT number: NCT02342444
Sponsor: Oregon Health and Science University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Trauma Surgery Deep Vein Thrombosis (DVT)Thromboembolic Events

Start date: 2014-02-01
Primary completion: 2024-12-31
Enrollment: 606

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.